August 15, 2025

Personalis, Inc. (PSNL) Stock Analysis: Navigating Challenges with a 51.56% Potential Upside

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector specializing in diagnostics and research, offers investors a unique opportunity amidst a challenging financial landscape...

Upstream Bio, Inc. (UPB) Stock Analysis: A Promising 166% Potential Upside in Biotechnology

For investors keen on the dynamic biotechnology sector, Upstream Bio, Inc. (NASDAQ: UPB) presents an intriguing opportunity. With a focus on developing novel treatments for inflammatory..

Talkspace, Inc. (TALK) Stock Analysis: Exploring an 89.72% Potential Upside for Investors

Talkspace, Inc. (NASDAQ: TALK) is garnering significant attention in the healthcare sector, particularly within the health information services industry. Known for its innovative virtual behavioral healthcare..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Riding High on an 83.70% Revenue Growth Surge

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands at the forefront of the biotechnology sector, making significant strides with its innovative therapeutic solutions for respiratory diseases. Based in..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 73% Potential Upside in the Medical Device Sector

For investors seeking opportunities in the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a compelling case, particularly given its significant potential upside. This medical device company,..

Auna SA (AUNA) Stock Analysis: Healthcare Potential with 95.68% Upside

Auna SA (AUNA), a prominent healthcare service provider headquartered in Luxembourg, is drawing significant attention from investors due to its potential for substantial upside. Operating hospitals..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: A High-Stakes Play with 274% Upside Potential

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology sector, is capturing the spotlight with its promising pipeline focused on childhood and adult..

Savara, Inc. (SVRA) Stock Analysis: Exploring a 158% Potential Upside in Biotechnology

Savara, Inc. (NASDAQ: SVRA) presents a compelling opportunity for investors in the biotech sector, with a staggering 158.66% potential upside, according to recent analyst ratings. As..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: A Closer Look at Its 20.14% Potential Upside

For investors keen on the healthcare sector, particularly in medical devices, Treace Medical Concepts, Inc. (NASDAQ: TMCI) presents a curious case of innovation and opportunity. Specializing..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a Promising 228% Potential Upside

MeiraGTx Holdings plc (MGTX), a promising player in the biotechnology sector, is capturing investor attention with a staggering potential upside of 228%. As a clinical-stage gene..

Praxis Precision Medicines (PRAX) Stock Analysis: Unveiling the Potential 116.63% Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, is gaining investor attention in the dynamic biotechnology sector. With a promising..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking the 228% Potential Upside

Investors keeping an eye on the biotechnology sector may find REGENXBIO Inc. (NASDAQ: RGNX) a compelling opportunity, particularly given the company’s significant potential upside. With a..

Replimune Group, Inc. (REPL) Stock Analysis: Understanding the Potential in Oncolytic Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL) stands at the forefront of innovation in the biotechnology sector, with a focus on developing and commercializing oncolytic immunotherapies to combat..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenging Waters with Potential for Future Growth

Surmodics, Inc. (SRDX), a key player in the healthcare sector, specializes in performance coating technologies for intravascular medical devices and chemical and biological components for in..

AMN Healthcare Services Inc (AMN): Investor Outlook with 8.65% Upside Potential

AMN Healthcare Services Inc (NYSE: AMN), a prominent name in the healthcare sector, stands as a vital player in the medical care facilities industry in the..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring a Potential 186% Upside in Biotechnology

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its robust development pipeline aimed at tackling various cancers...

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 3,585.87% Upside in Biotechnology

Cel-Sci Corporation (CVM), a clinical-stage biotechnology company, has captured the attention of investors with a staggering potential upside of 3,585.87%. This potential is reflected in the..

Ginkgo Bioworks Holdings, Inc. (DNA): Stock Analysis Reveals -19.90% Potential Downside Amidst Biotech Challenges

Ginkgo Bioworks Holdings, Inc. (DNA), a pioneering entity in the biotechnology sector, is at a critical juncture with its innovative approach to cell programming and biosecurity...

Geron Corporation (GERN) Stock Analysis: A Biotech Gem with 150% Potential Upside

For investors with an eye on the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents an intriguing opportunity. With a market capitalization of approximately $925.12 million, this..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Innovator with Nearly 95% Upside Potential

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, operates within the rapidly expanding field of health information services. With a market capitalization of..

Search

Funds

August 15, 2025

Search

Funds

August 15, 2025

FTSE 100

Funds